Strategies and policies to address the opioid epidemic: a case study of Ohio
Open accessAbstract
OBJECTIVE: To describe the strategies and policies implemented in Ohio to improve opioid safety and to discuss the role that pharmacists can play in implementing, promoting, and enhancing the effectiveness of these policies. SETTING: Ohio has the fifth highest rate of drug overdose deaths (24.6 deaths per 100,000) in the United States. Unintentional drug overdose has become the leading cause of injury-related death in Ohio. In 2015, there were 3050 overdose deaths in Ohio, and in 2014 there were an estimated 12,847 overdose events reversed by emergency medical services with naloxone. PRACTICE DESCRIPTION: Not applicable. PRACTICE POLICY INNOVATION: In 2011, the Governor's Cabinet Opiate Action Team was created to implement a multifaceted strategy, in part (1) to promote the responsible use of opioids, (2) to reduce the supply of opioids, and (3) to support overdose prevention and expand access to naloxone. Innovations to assist these goals include the development of Ohio guidelines on the responsible use of opioids, mandatory use of Ohio's prescription drug monitoring program, closing pill mills, promotion of drug take-back programs and increased access to naloxone and public health campaigns. EVALUATION: Not applicable. RESULTS: Since the development of the Governor's Cabinet Opiate Action Team, there were 81 million fewer doses of opioids dispensed to Ohio patients in 2015 compared with 782 million doses dispensed in 2011. As such, the proportion of unintentional drug overdose deaths involving prescription opioids has reduced from 45% in 2011 to 22% in 2015. CONCLUSION: Strong political support was crucial in Ohio to facilitate the rapid implementation opioid overdose prevention programs and the promotion of public awareness campaigns. However, the misuse and abuse of prescription opioids are complex problems requiring a comprehensive and multifaceted approach. Pharmacists are identified as a crucial component of the state strategy to addressing opioid abuse by promoting responsible prescribing and adopting prevention practices.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In 2016, Ohio passed a law that requires pharmacists to review a patient's PMDP history before dispensing a new controlled substance, encouraging denial to some patients and thereby taking a more proactive role in pain management.
“In 2016, Ohio passed a law that requires pharmacists to review a patient's PMDP history before dispensing a new controlled substance, encouraging denial to some patients and thereby taking a more proactive role in pain management (194).”
From A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health (2019) · cites this paper as [194]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Increases in drug and opioid overdose deaths — United States, 2000–2014
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6450a3 · Cited by 1,859 · see citing works
Opioid Prescriptions for Chronic Pain and Overdose
Dunn, K. M., Saunders, K. W., Rutter, C. M., Banta‐Green, C. J., Merrill, J. O., Sullivan, M. D., Weisner, C. M., Silverberg, M. J., Campbell, C. I., Psaty, B. M., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00006 · Cited by 1,265 · see citing works
Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013) · BMJ · doi:10.1136/bmj.f174 · Cited by 999 · see citing works
Increases in Drug and Opioid Overdose Deaths—United States, 2000–2014
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13776 · Cited by 352 · cited 3× · see citing works
“Practice policy innovation—In 2011, the Governor's Cabinet Opiate Action Team was created to implement a multifaceted strategy, in part (1) to promote the responsible use of opioids, (2) to reduce the supply of opioids, and (3) to support overdose prevention and expand access to naloxone.”
BackgroundPatrick, S. W., Fry, C., Jones, T. F., & Buntin, M. B. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1496 · Cited by 301 · see citing works
Office-Based Management of Opioid Dependence with Buprenorphine: Clinical Practices and Barriers
Walley, A. Y., Alperen, J. K., Cheng, D. M., Botticelli, M. P., Castro-Donlan, C., Samet, J. H., & Alford, D. P. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0686-x · Cited by 220 · see citing works
Mandatory Use of Prescription Drug Monitoring Programs
Haffajee, R. L., Jena, A. B., & Weiner, S. G. (2015) · JAMA · doi:10.1001/jama.2014.18514 · Cited by 212 · see citing works
Preventing Opiate Overdose Deaths: Examining Objections to Take-Home Naloxone
Bazazi, A. R., Zaller, N. D., Fu, J. J., & Rich, J. D. (2010) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2010.0935 · Cited by 73 · see citing works
Barriers to Implementation of Opioid Overdose Prevention Programs in Ohio
Winstanley, E. L., Clark, A. K., Feinberg, J., & Wilder, C. M. (2015) · Substance Abuse · doi:10.1080/08897077.2015.1132294 · Cited by 71 · see citing works
Self-citationGray, J. A., & Hagemeier, N. E. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.2374 · Cited by 43 · see citing works
Dembe, A. E., Wickizer, T. M., Sieck, C. J., Partridge, J. S., & Balchick, R. (2011) · American Journal of Industrial Medicine · doi:10.1002/ajim.21021 · Cited by 35 · see citing works
Pharmacists’ role in addressing opioid abuse, addiction, and diversion
American Pharmacists Association (2013) · Journal of the American Pharmacists Association · doi:10.1331/japha.2014.13101 · Cited by 34 · see citing works
Prescription Drug Abuse as a Public Health Problem in Ohio: A Case Report
Winstanley, E. L., Gay, J., Roberts, L., Moseley, J., Hall, O. T., Beeghly, B. C., Winhusen, T. M., & Somoza, E. C. (2012) · Public Health Nursing · doi:10.1111/j.1525-1446.2012.01043.x · Cited by 18 · cited 3× · see citing works
“The American Pharmacists Association has previously identified pharmacists' role in addressing nonmedical opioid use, opioid use disorder, and diversion, which include: (1) identifying potential opioid use disorder by evaluating patients and prescriptions; (2) managing the risk of opioid misuse by establishing policie…”
BackgroundMethodSelf-citationThe Ohio Legislative Service Commission
Ruud, M. H. (1953) · The Knowledge Bank (The Ohio State University) · Cited by 7 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [8]Beeghly C Response to Ohio's prescription drug overdose epidemic: prescribing guidelines Proceedings of the Preventing Injury: From Research to Practice to People Conference 2013 Sept. 30–Oct. 1 Ann Arbor, MI University of Michigan Injury Center 2013
Cited by
Sorted by citations
Current perspectives on the opioid crisis in the US healthcare system
Stoicea, N., Costa, A. P., Periel, L., Uribe, A. A., Weaver, T. E., & Bergese, S. D. (2019) · Medicine · doi:10.1097/md.0000000000015425 · Cited by 182 · see citing works
McDonald, R., CAMPBELL, N. D., & Strang, J. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.05.001 · Cited by 147 · see citing works
“patients’ opioid prescriptions and assessing their risk of opioid use disorder as well as b) expansion of naloxone access (Green et al., 2015b; Penm et al., 2017).”
BackgroundDezfulian, C., Orkin, A. M., Maron, B. A., Elmer, J., Girotra, S. R., Gladwin, M. T., Merchant, R. M., Panchal, A. R., Perman, S. M., Starks, M. A., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000958 · Cited by 150 · see citing works
Meisenberg, B. R., Grover, J., Campbell, C., & Korpon, D. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.2908 · Cited by 123 · see citing works
Sarker, A., Gonzalez-Hernandez, G., Ruan, Y.-C., & Perrone, J. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.14672 · Cited by 103 · see citing works
Pharmacist roles, training, and perceived barriers in naloxone dispensing: A systematic review
Thakur, T., Frey, M. C., & Chewning, B. A. (2019) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2019.06.016 · Cited by 93 · see citing works
Opioid Utilization Following Lumbar Arthrodesis
Kalakoti, P., Hendrickson, N. R., Bedard, N. A., & Pugely, A. J. (2018) · Spine · doi:10.1097/brs.0000000000002734 · Cited by 90 · see citing works
Meyerson, B. E., Agley, J. D., Davis, A., Jayawardene, W. P., Hoss, A., Shannon, D. J., Ryder, P. T., Ritchie, K., & Gassman, R. A. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.03.032 · Cited by 89 · see citing works
“, 2016) or more generalized stigma related to naloxone (Zaller et al., 2013; Green et al., 2017b; Penm et al., 2017).”
BackgroundEvidence for state, community and systems-level prevention strategies to address the opioid crisis
Haegerich, T. M., Jones, C. M., Cote, P.-O., Robinson, A. B., & Ross, L. B. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107563 · Cited by 89 · see citing works
“Eight studies evaluated PDMPs in combination with other state policies [Al Achkar et al., 2018; Chang et al., 2016; Dowell et al., 2016; Johnson et al., 2014; Meara et al., 2016; Penm et al., 2017; Rutkow et al., 2015; Surratt et al., 2014]).”
BackgroundDARK Classics in Chemical Neuroscience: Morphine
Devereaux, A. L., Mercer, S. L., & Cunningham, C. W. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00150 · Cited by 86 · see citing works
Dispensing Naloxone Without a Prescription: Survey Evaluation of Ohio Pharmacists
Thompson, E. L., Rao, S., Hayes, C., & Purtill, C. (2018) · Journal of Pharmacy Practice · doi:10.1177/0897190018759225 · Cited by 48 · see citing works
Pharmacist Services in the Opioid Crisis: Current Practices and Scope in the United States
Thakur, T., Frey, M. C., & Chewning, B. A. (2019) · Pharmacy · doi:10.3390/pharmacy7020060 · Cited by 46 · see citing works
Epidemiological and geospatial profile of the prescription opioid crisis in Ohio, United States
Hernández, A., Branscum, A. J., Li, J., MacKinnon, N. J., Hincapie, A. L., & Cuadros, D. F. (2020) · Scientific Reports · doi:10.1038/s41598-020-61281-y · Cited by 45 · see citing works
Self-citationState Responses to the Opioid Crisis
Parker, A. M., Strunk, D., & Fiellin, D. A. (2018) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110518782946 · Cited by 44 · see citing works
The Role of the Pharmacist in Combating the Opioid Crisis: An Update
Kosobuski, L., O’Donnell, C., Koh-Knox, C. P., Chen, N., & Palombi, L. C. (2022) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s351096 · Cited by 43 · see citing works
“One study investigating the PDMP in Ohio identified a reduction in opioid prescriptions and doctor shopping after the PDMP was implemented.(32) Tools such as the Opioid Risk Tool (ORT) and the Current Opioid Misuse Measure (COMM)TM screen for opioid misuse in patients.”
BackgroundA Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health
Wiss, D. A. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00193 · Cited by 41 · see citing works
“In 2016, Ohio passed a law that requires pharmacists to review a patient’s PMDP history before dispensing a new controlled substance, encouraging denial to some patients and thereby taking a more proactive role in pain management (194).”
BackgroundOpioid Treatment Deserts: Concept development and application in a US Midwestern urban county
Hyder, A., Lee, J., Dundon, A., Southerland, L. T., All, D., Hammond, G. C., & Miller, H. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250324 · Cited by 41 · see citing works
Investigate Transitions into Drug Addiction through Text Mining of Reddit Data
Lu, J. L., Sridhar, S., Pandey, R., Hasan, M. A., & Mohler, G. (2019) · ACM SIGKDD Conference on Knowledge Discovery and Data Mining (KDD) · doi:10.1145/3292500.3330737 · Cited by 40 · see citing works
“While recent efforts have been made to curb over-prescribing [3, 18], morbidity and mortality rates associated with opioid misuse continue to worsen [25].”
BackgroundMatulewicz, R. S., Patel, M. S., Jordan, B. J., Morano, J. M., Frainey, B. T., Bhanji, Y., Bux, M., Nader, A., KUNDU, S. D., & Meeks, J. J. (2018) · Bladder Cancer · doi:10.3233/blc-170157 · Cited by 36 · see citing works
“Opioid abuse has increased substantially over time and various initiatives have been made to combat the epidemic [22, 23].”
State-level variation in the relationship between child removals and opioid prescriptions
Quast, T. C. (2018) · Child Abuse & Neglect · doi:10.1016/j.chiabu.2018.10.001 · Cited by 32 · see citing works
Nasralah, T., El-Gayar, O., & Wang, Y. (2020) · Journal of Medical Internet Research · doi:10.2196/18350 · Cited by 31 · see citing works
“Example policies and strategies include promoting the responsible use of opioids, reducing the supply of opioids, implementing drug take-back programs [29], tracking and monitoring prescription drug abuse, and reporting electronic prescriptions [30].”
BackgroundPolydrug use among heroin users in Cleveland, OH
Bobashev, G., Tebbe, K., Peiper, N. C., & Hoffer, L. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.06.039 · Cited by 29 · see citing works
Impact of an Opioid Safety Initiative on Patients Undergoing Total Knee Arthroplasty
Chen, Q., Hsia, H.-L. J., Overman, R. A., Bryan, W. E., Pepin, M. J., Mariano, E. R., Mudumbai, S. C., Buchheit, T., Krishnamoorthy, V. K., Good, C. B., et al. (2019) · Anesthesiology · doi:10.1097/aln.0000000000002771 · Cited by 27 · see citing works
Hoppe, D., Ristevski, E., & Khalil, H. (2019) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13100 · Cited by 26 · see citing works
Using role theory to explore pharmacist role conflict in opioid risks communication
Thakur, T., & Chewning, B. A. (2019) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2019.11.012 · Cited by 19 · see citing works
Penm, J. H.-D., MacKinnon, N. J., Connelly, C., Mashni, R., Lyons, M. S., Hooker, E. A., Winstanley, E. L., Carlton‐Ford, S., Tolle, E., Boone, J., et al. (2018) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2018.09.005 · Cited by 18 · see citing works
“In response to this, Ohio implemented multifaceted strategies to address opioid use disorder and overdose deaths, including a strong focus on preventing the nonmedical use of prescription drugs (5).”
BackgroundSelf-citationBobashev, G., & Warren, L. K. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109553 · Cited by 17 · see citing works
“The opioid epidemic is growing in the United States, and reports show that more than one drug accompanies overdoses (Dasgupta et al., 2018; Liu et al., 2021; McCabe et al., 2006; McCall Jones et al., 2017; National Institute on Drug Abuse, 2021; Penm et al., 2017).”
BackgroundChavez, L., Cooper, J., Deans, K., Wrona, S. K., Zaim, H., Sebastião, Y., & Chisolm, D. J. (2020) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2020.07.024 · Cited by 16 · see citing works
Bowen, E. A., & Irish, A. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.09.014 · Cited by 17 · see citing works
Whale, C. S., Henningsen, J. D., Huff, S., Schneider, A. D., Hijji, F. Y., & Froehle, A. W. (2020) · The Journal of Arthroplasty · doi:10.1016/j.arth.2020.04.036 · Cited by 16 · see citing works
Re-emergence of Congenital Syphilis in Ohio
Cooper, J. M., Porter, M., Bazan, J. A., Nicholson, L., & Sánchez, P. J. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001995 · Cited by 16 · see citing works
Asamoah-Boaheng, M., Badejo, O. A., Bell, L. V., Buckley, N., Busse, J. W., Campbell, T. S., Corace, K., Cooper, L., Flusk, D., Garcia, D. A., et al. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.07.012 · Cited by 15 · see citing works
Student pharmacist perceptions of participation in hands-on naloxone counseling
Hines, J. A., Deja, E. N., & Black, E. P. (2018) · Currents in Pharmacy Teaching and Learning · doi:10.1016/j.cptl.2018.03.002 · Cited by 14 · see citing works
Perdue, T., Carlson, R. G., Daniulaityte, R., Silverstein, S. M., Bluthenthal, R. N., Valdez, A., & Cepeda, A. (2023) · Social Science & Medicine · doi:10.1016/j.socscimed.2023.116441 · Cited by 12 · see citing works
Lardier, D. T., Powell, K. G., Peterson, N. A., Borys, S. V., & Hallcom, D. K. (2022) · Substance Abuse · doi:10.1080/08897077.2022.2060436 · Cited by 12 · see citing works
“In high risk areas of the United States, examining emerging patterns of polysubstance use among individuals who use opioids may help understand substance preference,(20) which can help shape policy and practice around emerging drug markets and social norms.(21) In addition, documenting variations related to age of sub…”
BackgroundTrends in Opioid Misuse among Marijuana Users and Non-Users in the U.S. from 2007–2017
Azagba, S., Shan, L., Manzione, L. C., Qeadan, F., & Wolfson, M. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16224585 · Cited by 11 · see citing works
Cuadros, D. F., Branscum, A. J., Moreno, C. M., & MacKinnon, N. J. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i11.2374 · Cited by 8 · see citing works
Self-citationRedditors in Recovery: Text Mining Reddit to Investigate Transitions into Drug Addiction
Lu, J. L., Sridhar, S., Pandey, R., Hasan, M. A., & Mohler, G. (2018) · IEEE International Conference on Big Data (BigData) · doi:10.1109/bigdata.2018.8622552 · Cited by 7 · see citing works
“While recent efforts have been made to curb over-prescribing [1], [2], morbidity and mortality rates associated with opioid misuse continue to worsen [3].”
BackgroundA MULTIVARIATE SPATIOTEMPORAL CHANGE-POINT MODEL OF OPIOID OVERDOSE DEATHS IN OHIO
Hepler, S. A., Waller, L., & Kline, D. (2021) · Annals of Applied Statistics · doi:10.1214/20-aoas1415 · Cited by 7 · see citing works
“While our analysis is not causal or a formal policy evaluation, the timing and direction of the changing trends fits with larger policy interventions taking place in Ohio (Penm et al., 2017; Governor’s Cabinet Opiate Action Team, 2018).”
BackgroundDeokar, A. J., Dellapenna, A., DeFiore-Hyrmer, J., Laidler, M., Millet, L. M., Morman, S., & Myers, L. M. (2017) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000000704 · Cited by 7 · see citing works
“To maintain opioid abuse prevention as a state priority, the current governor established the Governor’s Cabinet Opiate Action Team (GCOAT).(35) The state’s prescriber education workgroup, created by GCOAT, released 3 sets of prescribing guidelines: for pain management in emergency departments and”
Facilitating community partnerships to reduce opioid overdose: An engaged department initiative
Palombi, L. C., LaRue, A., & Fierke, K. K. (2018) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2018.07.002 · Cited by 7 · see citing works
Morphine Equivalent Total Dosage as Predictor of Adverse Outcomes in Opioid Prescribing
Bonifonte, A., Merchant, R. F., & Deppen, K. (2021) · Pain Medicine · doi:10.1093/pm/pnab249 · Cited by 7 · see citing works
Criminal court responses to the modern opioid and methamphetamine twindemic
Holmes, B., Feldmeyer, B., Sun, D. K., & Arrigo, S. R. (2024) · Journal of Criminal Justice · doi:10.1016/j.jcrimjus.2024.102167 · Cited by 6 · see citing works
Rao, V. K., Valdez, D., Muralidharan, R., Agley, J. D., Eddens, K. S., Dendukuri, A., Panth, V., & Parker, M. A. (2024) · Journal of Medical Internet Research · doi:10.2196/57885 · Cited by 6 · see citing works
“While major strides have been made in attenuating the harm from this crisis, such as increasing access to naloxone [21,22] and harm-reduction strategies [23], the persistence of harmful outcomes associated with drug use suggests that additional strategies and information are needed.”
Sidorov, G., Ahmad, M., Basile, P., Waqas, M., Orji, R., & Batyrshin, I. (2025) · JMIR Infodemiology · doi:10.2196/77279 · Cited by 5 · see citing works
“Existing surveillance systems are hindered by considerable delays, making it difficult to evaluate the immediate impact of new policies and interventions [8-10].”
Penm, J. H.-D., MacKinnon, N. J., Mashni, R., Lyons, M. S., Hooker, E. A., Winstanley, E. L., Carlton‐Ford, S., Connelly, C., Tolle, E., Boone, J., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020477 · Cited by 5 · see citing works
“Obtained records from other providers 16 (12) 39 (29) 24 (18) 17 (13) 8 (6) 8 (6) 7 (5)”
Self-citationCrothers, G., Edwards, D. A., Ehrenfeld, J. M., Woo, E., McCluggage, L. K., & Lobo, B. (2019) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2019.02.010 · Cited by 5 · see citing works
Chen, A. M. H., Gardner, J. C., Wandling, E., Wicker, E., Grauer, P. A., & Sweeney, M. A. (2022) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2022.04.001 · Cited by 4 · see citing works
Addressing the Opioid Crisis through an Interdisciplinary Task Force in Cincinnati, Ohio, USA
MacKinnon, N. J., & Privitera, E. M. (2020) · Pharmacy · doi:10.3390/pharmacy8030116 · Cited by 4 · see citing works
Self-citationSibley, A. L., Noar, S. M., Muessig, K. E., Gottfredson, N. C., Paquette, C. E., Spears, A. G., Miller, W. C., & Go, V. F.-L. (2024) · JMIR Research Protocols · doi:10.2196/59224 · Cited by 3 · see citing works
Mixed Methods Evaluation of State Targeted Response to the Opioid Crisis in Ohio
Sherba, R. T., Dionne, J., & Linley, J. V. (2023) · Ohio Journal of Public Health · doi:10.18061/ojph.v5i2.8979 · Cited by 3 · see citing works
Elder, J. W., Gu, Z., Kim, J., Moulin, A. K., Bang, H., Parikh, A. K., & May, L. S. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.10.029 · Cited by 3 · see citing works
The pharmacists' contribution against opioid addiction
Wertheimer, A. I., & Lai, L. (2020) · Journal of Pharmaceutical Health Services Research · doi:10.1111/jphs.12374 · Cited by 2 · see citing works
Iwuchukwu, O. F., & Kim, D. (2023) · American Journal of Pharmacotherapy and Pharmaceutical Sciences · doi:10.25259/ajpps_2023_022 · Cited by 2 · see citing works
Recovery From Heroin Addiction: A Qualitative Study
Krowka, J., & Aller, L. J. (2024) · Public Health Nursing · doi:10.1111/phn.13526 · Cited by 2 · see citing works
“Since 1999, the rates of heroin addiction and overdose have surged, contributing to a national opioid epidemic (Kolodny et al. 2015; Leahy 2017; Penm et al. 2017; Winstanley et al. 2016).”
Battista, N., Pearcy, L. B., & Strickland, C. (2017) · Cited by 2 · see citing works
Text Mining for Social Harm and Criminal Justice Applications
Pandey, R. (2020) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2375 · Cited by 2 · see citing works
Addressing the Opioid Crisis: Community Partnerships in Primary Care
Weinand, J. D., Huckaby, A., Chavez, O., Sharma, R. H., Lara, J., Leija, L., Morriss, C., Rowland, S., Norris, D. M., de Ramirez, M. M., et al. (2019) · PRiMER · doi:10.22454/primer.2019.649767 · Cited by 1 · see citing works
Effects of Ohio Opioid Prescribing Policy on Postsurgical Prescriptions Following Sports Procedures
Henningsen, J. D., Huff, S., Schneider, A. M., Hijji, F. Y., Froehle, A. W., & Krishnamurthy, A. (2022) · Journal of Sports Medicine and Allied Health Sciences Official Journal of the Ohio Athletic Trainers Association · doi:10.25035/jsmahs.08.03.03 · Cited by 1 · see citing works
Descriptive Analysis of the Most Viewed Youtube Videos Related to the Opioid Epidemic
Randolph-Krisova, A. (2018) · doi:10.7916/d8x36dxs · Cited by 1 · see citing works
“3 When prescription opioids became less accessible, or when individuals could not afford to buy them at the “pill mills” (Penm et al., 2017), those who were dependent often turned to the black market (Foggers & McGuiness, 2014).”
BackgroundInfluentialJosephson, B. W., Vadakkepatt, G., & Greenwood, B. N. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.3928945 · Cited by 1 · see citing works
Ohio Journal of Public Health Vol. 5, Issue 2 (July 2023): Full Issue
Ohio Public Health Association OPHA (2023) · Ohio Journal of Public Health · doi:10.18061/ojph.v5i2.9598 · Cited by 1 · see citing works
Schenkier, L. A. (2018) · Digital Commons-DePaul (DePaul University)
A Dynamic Model of Opioid Epidemic based on Cellular Automata and Principal Component Analysis
Wang, Y., Chen, L., He, J., Chen, L., Chen, J., & Jiang, L. (2019) · International Conference on Bioinformatics and Biomedical Science (ICBBS) · doi:10.1145/3369166.3369190
“Jonathan Penm et al described the strategies and policies implemented in Ohio to improve opioid safety [4].”
BackgroundThe Opioid Requiring Patient: Systems Level Management
Hall, B. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-47117-0_10
The Rise And Fall Of The Opioid Crisis: A Comparative State By State Study
Bouthillette, A. (2019) · doi:10.26153/tsw/2525
Bennett, N. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733207320.793556442
Curcillo, K., Drees, S. M., Najjar, J. A., Southard, E., Davis, A., Huss, C., & Singh, T. (2024) · Translation The University of Toledo Journal of Medical Sciences · doi:10.46570/utjms-2024-1158
Preventing Fentanyl-Related Overdose Deaths with Naloxone—A Medical Examiner Study
Alexander, G., Ferreira, P. A., Dean, S. A., & Alexander, R. T. (2025) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0000000000001028
Legislative Changes on Opioid Prescriptions for Ocular Procedures in a United States Cohort
Singh, P. T., Shaia, J. K., Rich, J. J., Zhang, D., Singh, R. P., & Talcott, K. E. (2025) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20250127-04
CrossFit as Adjunctive Treatment in Substance Use Disorders
Klotzbaugh, R. J., Jakub, K., & Skrovanek, E. (2025) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000619
“Inclusion criteria for this (Penm et al., 2017; Ulloa, 2019).”
Wagi, C. R., Murphy, J., Enderle, M. N., Piscalko, H. M., Egan, K. L., Meade, C. S., Freisthler, B., Young, A. M., Estadt, A. T., & Lancaster, K. E. (2026) · Harm Reduction Journal · doi:10.1186/s12954-026-01450-w
“Although these data were collected in 2021, subsequent expansions in harm reduction services (e.g., nalox-one distribution and syringe services) and shifts in drug supply may have influenced current patterns of risk and service engagement [39, 40].”
Area-specific autoencoder spatiotemporal graph neural networks for opioid overdose death prediction
Chen, X., Yin, C., Myers, J. V., Slover, B., Thomas, N., Marks, C., Kim, J., Fernandez, S., Whitley, P., Fareed, N., et al. (2026) · JAMIA Open · doi:10.1093/jamiaopen/ooag063
- Authors
- Penm, J., MacKinnon, N. J., Boone, J. M., Ciaccia, A., McNamee, C., & Winstanley, E. L.
- Affiliations
- West Virginia University (US)
- Corresponding author
- Penm, Jonathan
- Venue
- Journal of the American Pharmacists Association
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 57
- Issue
- 2
- Pages
- S148-S153
- ISSN
- 1544-3191 (ISSN-L)
- PMC
- PMC5497298
- OpenAlex
- W2587448567
- Cited by
- 73
- References
- 14
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 6 · 2021: 5 · 2020: 9 · 2019: 17 · 2018: 17 · 2017: 3
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of the American Pharmacists Association (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (acceptedVersion, cc-by-nc-nd)
- The Research Repository @ WVU (West Virginia University) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (U54GM104942)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- opioid epidemic, prescription opioid misuse, opioid overdose prevention, naloxone access, prescription drug monitoring programs, drug take-back programs, drug overdose deaths
- MeSH terms
- Analgesics, Opioid, Health Policy, Health Services Accessibility, Humans, Naloxone, Narcotic Antagonists, Opioid-Related Disorders, Ohio, Pharmaceutical Services, Pharmacists, Public Health, Professional Role, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
